Biologic DMARD Response Reduces After 3 Months in Juvenile Idiopathic Arthritis Rheumatology Advisor, 12 Sep 2022 Patients with juvenile idiopathic arthritis (JIA) who do not demonstrate early responses to treatment with a new biologic agent…